Genentech USA, Inc Contracts with Department of Health and Human Services
Relationship Overview
Total Contract Value: $142,591,864
Contract Count: 3
Average Contract Size: $47.5M
Sole Source Rate: 0%
Small Business Rate: 0%
Spending by Sector
- Other: $142.6M (3 contracts)
Contracts
- THE PURPOSE AND NEED FOR THIS PROPOSED REQUIREMENT IS TO PROVIDE THE DIVISION OF STRATEGIC NATIONAL STOCKPILE (DSNS), ASSISTANT SECRETARY OF PREPAREDNESS AND RESPONSE (ASPR), WITH A CONTRACTING VEHICLE FOR PRODUCT(S) NEEDED IN ORDER TO SUPPORT " — $60.0M
- OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES — $45.1M
- PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS — $37.5M
Frequently Asked Questions
How many contracts does Genentech USA, Inc have with Department of Health and Human Services?
Genentech USA, Inc has 3 contracts with Department of Health and Human Services worth a combined $142.6M.
What is the average contract size between Genentech USA, Inc and Department of Health and Human Services?
The average contract size is $47.5M.
What percentage of Genentech USA, Inc's contracts with Department of Health and Human Services are sole-source?
0% of the contracts are sole-source awards.